Ketanserin in combination with beta‐adrenergic receptor blocking agents in the treatment of essential hypertension.

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

1981 • 848 citations

Statistical methods in research and production

1950 • 513 citations

Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

1981 • 511 citations

Mechanism of the Hypotensive Effect of Ketanserin

1982 • 183 citations

Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.

1982 • 104 citations

Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

1982 • 90 citations

Mechanism of antihypertensive action of ketanserin in man.

1983 • 81 citations

5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.

1984 • 76 citations

Ketanserin, a novel 5‐hydroxytryptamine antagonist: monotherapy in essential hypertension.

1983 • 64 citations

The Antihypertensive Effects of a Pure and Selective Serotonin-Receptor Blocking Agent (R 41 468) in Elderly Patients

1981 • 58 citations

Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent

1982 • 50 citations

5-HT2-RECEPTOR BLOCKADE IN THE TREATMENT OF HEART FAILURE

1981 • 42 citations

Ketanserin in essential hypertension: Effects during rest and exercise

1983 • 38 citations

High-performance liquid chromatographic assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S2 antagonist in human plasma, blood and urine

1983 • 28 citations

Ketanserin in Hypertension

1983 • 26 citations

Indirect blood pressure and heart rate measured quickly without observer bias using a semi‐automatic machine (auto‐manometer)‐response to isometric exercise in normal healthy males and its modification by beta‐adrenoceptor blockade.

1977 • 19 citations

Treatment of hypertension at an outpatient hypertension clinic. Blood pressure control, dropout rate, and side effects

1982 • 19 citations

Experience With Ketanserin, A Serotonin (S₂) Antagonist, in Longterm Treatment of Essential Hypertension

1984 • 11 citations